Abano Healthcare Group Limited reaffirmed financial guidance for fiscal 2017. The company confirms it is on track to achieve results for the fiscal 2017 full year in line with the forecasts provided earlier in December 2016. The company expects, revenue to be in the range of $231 to $235 million; EBITDA to be in the range of $30.7 ­ to $31.9 million; underlying EBITDA to be in the range of $31.5 to $­32.7 million; NPAT to be in the range of $9.7 ­ to $10.5 million; and underlying NPAT to be in the range of $10.7 ­ to $11.5 million.